<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04834635</url>
  </required_header>
  <id_info>
    <org_study_id>FundoRingOAGB</org_study_id>
    <nct_id>NCT04834635</nct_id>
  </id_info>
  <brief_title>The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass</brief_title>
  <acronym>FundoRingMGB</acronym>
  <official_title>The Total Wrapping of the Fundus of the Gastric Excluded Part (FundoRing) Versus Non- Wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass/Mini - Gastric Bypass: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Society of Bariatric and Metabolic Surgeons of Kazakhstan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Society of Bariatric and Metabolic Surgeons of Kazakhstan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common&#xD;
      bariatric procedure for treating obesity. Weight gain after surgery is a big problem in&#xD;
      bariatric practice. Therefore, adjustable bands and rings are used, for example, &quot;FobiRing&quot;.&#xD;
      But foreign material can cause complications - the erosion of the stomach wall. For this&#xD;
      reason, surgeons avoid the use of various mechanical devices on living tissues.&#xD;
&#xD;
      The greatest criticism is of the OAGB for the likelihood of biliary reflux. In case of reflux&#xD;
      of bile into the esophagus after surgery, as a rule, a second operation is required with&#xD;
      conversion OAGB to the Roux-en-Y method.&#xD;
&#xD;
      In addition, along with obesity, gastroesophageal reflux disease (GERD) are steadily&#xD;
      increasing world weight and antireflux surgery must be performed simultaneously with&#xD;
      bariatric surgery in obese patients. In these cases, most often in bariatric practice, hiatus&#xD;
      cruroraphy is performed, and less often fundoplication using the fundus of the excluded part&#xD;
      of the stomach.&#xD;
&#xD;
      We hypothesize that total fundoplication can not only treat GERD but also significant prevent&#xD;
      the return of weight like after a banded gastric bypass and prevent postoperative bile reflux&#xD;
      in the esophagus.&#xD;
&#xD;
      The aim study is to compare primary outcome as weight loss after total wrapping of the fundus&#xD;
      of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of&#xD;
      laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the&#xD;
      esophagus and GERD symptoms.&#xD;
&#xD;
      Methods: Adult participants (n=100) are randomly allocated to one of two groups:&#xD;
&#xD;
      Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric&#xD;
      excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active&#xD;
      comparator surgical bariatric procedure in the second (B) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present&#xD;
      hiatal hernia (OAGB group).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is gaining popularity as a&#xD;
      primary surgical treatment for morbid obesity.&#xD;
&#xD;
      The aim study is to compare primary outcome as weight loss after total wrapping of the fundus&#xD;
      of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of&#xD;
      laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the&#xD;
      esophagus and GERD symptoms.&#xD;
&#xD;
      Methods: Adult participants (n=100) are randomly allocated to one of two groups:&#xD;
&#xD;
      Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric&#xD;
      excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active&#xD;
      comparator surgical bariatric procedure in the second (B) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present&#xD;
      hiatal hernia (OAGB group). All patients are then followed up 12, 24, 36 months after surgery&#xD;
      where record the changing body mass index and and measure secondary outcome: bile reflux in&#xD;
      the esophagus and GERD symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">May 10, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 5, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of body mass index</measure>
    <time_frame>Baseline, at 12, 24, 36 months after surgery</time_frame>
    <description>The measure is assessing a change of body mass index. Weight (kg) and height (cm) will be combined with the report of measurement by body mass index (BMI) kg/m2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative bile reflux in esophagus</measure>
    <time_frame>at 12, 24, 36 months after surgery</time_frame>
    <description>The endoscopic finding of postoperative bile reflux in the esophagus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD symptoms</measure>
    <time_frame>Baseline, 12, 24, 36 months after surgery</time_frame>
    <description>Change og GERD symptoms if present GERD or postoperative de Novo GERD symptoms (GERD-HRQL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>FundoRingOAGB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part (and suture cruroplasty if present hiatal hernia).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OAGB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic one anastomosis gastric bypass (and suture cruroplasty if present hiatal hernia).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FundoRingOAGB</intervention_name>
    <description>laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and with suture cruroplasty if present hiatal hernia</description>
    <arm_group_label>FundoRingOAGB group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OAGB</intervention_name>
    <description>laparoscopic one anastomosis gastric bypass with suture cruroplasty if present hiatal hernia</description>
    <arm_group_label>OAGB group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI from 30 to 50 kg / m2.&#xD;
&#xD;
          -  The person is generally fit for anesthesia (ASA grading 1-2) and surgery.&#xD;
&#xD;
          -  The person commits to the need for long-term follow-up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI less than 30 kg / m2 and more than 50 kg / m2.&#xD;
&#xD;
          -  Prosthetic (mesh) Hiatal herniorrhaphy or large hiatal hernia;&#xD;
&#xD;
          -  Esophageal shortening&#xD;
&#xD;
          -  Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis&#xD;
&#xD;
          -  History of surgery on the stomach or esophagus&#xD;
&#xD;
          -  Less than 18 or more than 60 years of age&#xD;
&#xD;
          -  Not fit for bariatric surgery&#xD;
&#xD;
          -  Psychiatric illness&#xD;
&#xD;
          -  Patients unwilling or unable to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oral Ospanov</last_name>
    <role>Principal Investigator</role>
    <affiliation>President of Society of Bariatric and Metabolic Surgeons of Kazakhstan&quot; (SBMSK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oral Ospanov, Professor</last_name>
    <phone>+77015287734</phone>
    <email>bariatric.kz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bakhtiyar Yelembayev</last_name>
    <phone>+77071302383</phone>
    <email>elembaevbaha@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oral Ospanov</name>
      <address>
        <city>Astana</city>
        <zip>010000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oral Ospanov, Professor</last_name>
      <phone>+77015287734</phone>
      <email>bariatric.kz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Bakhtiyar Yelembaev</last_name>
      <phone>+77071302383</phone>
      <email>elembaevbaha@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Kazakhstan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 4, 2021</study_first_submitted>
  <study_first_submitted_qc>April 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 4, 2021</last_update_submitted>
  <last_update_submitted_qc>April 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Bariatric surgery</keyword>
  <keyword>One anastomosis gastric bypass</keyword>
  <keyword>FundoRingOAGB</keyword>
  <keyword>Fundoplication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

